1041Implementation of a Chronic Hepatitis Panel to Improve Viral Hepatitis Screening in Chronic Liver Diseasedoi:10.14309/01.ajg.0000593700.15754.29Umapathy, ChandraprakashPham, JonathanStokes, LindaRoytman, MarinaOfficial journal of the American College of Gastroenterology | ACG...
He remarked on the usefulness of meetings such as this in defining differences in the way in which clinicians in the United States and Japan approach the management of patients with chronic hepatitis. 展开 关键词: Humans Flaviviridae Hepatitis, Viral, Human Hepatitis C ...
A liver panel can be used to help diagnose and monitor liver diseases. It can also provide information about other health conditions that affect the liver, such as viral or alcoholic hepatitis. If you are taking medications that can impact the liver, the test results can determine whether side...
Spatio-temporal epidemiology of viral Hepatitis in China (2003–2015): implications for Prevention and Control policies. Int J Environ Res Public Health. 2018;15(4):661. Mao Y, Zhang N, Zhu B, Liu J, He R. A descriptive analysis of the Spatio-temporal distribution of intestinal infectious...
This panel may be useful in evaluating individuals who are taking hepatotoxic drugs as well as those with viral hepatitis, symptoms or signs of chronic liver disease, conditions associated with a high risk of developing liver disease, lifestyle risk factors for nonalcoholic fatty liver disease, or...
An accurate and reliable quantitative assay for hepatitis C virus (HCV) is essential for measuring viral propagation and the efficacy of antiviral therapy. There is a growing need for domestic reference panels for evaluation of clinical assay kits because the performance of these kits may vary with...
Load Testing Scale-Up of High-Throughput HIV Viral Use of a Prequalification Panel for RapidIncreased access to antiretroviral drugs expands needs for viral... M Mackay,W Stevens,L Scott,... 被引量: 0发表: 2013年 Natural smoke filling in atrium with liquid pool fires up to 1.6 MW Experim...
Like HIV drugs, the new drugs from Merck and Vertex will be prescribed as part of a cocktail with two older drugs to help lower viral levels. Thursday's panel discussion highlighted several advantages of Vertex's drug over its Merck counterpart. The cure rate for new patients taking telaprevir...
The new diagnosis rate for HIV, Hepatitis B and Hepatitis C was 0.8, 2.26 and 6.5 per 1000 and study prevalence for HIV, Hepatitis B and Hepatitis C was 11.0, 5.0 and 50.5 per 1000 respectively. Opt-out blood borne viral screening was feasible and acceptable in an inner-city ED. Blood...
Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy. Hepatitis C virus subgenotypes 1a and 1b are found worldwide and cause 60% of all hepatitis C cases. It has been reported recently that viral genetic va...